Financial Snapshot

Revenue
$11.29M
TTM
Gross Margin
15.72%
TTM
Net Earnings
-$135.3M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
332.94%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$74.21M
Q3 2024
Cash
Q3 2024
P/E
-0.2404
Nov 29, 2024 EST
Free Cash Flow
-$69.19M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $7.768M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $53.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Revenue $7.768M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $53.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $4.741M
Gross Profit $3.027M $0.00
Gross Profit Margin 38.97%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Selling, General & Admin $34.75M $30.22M $23.47M $14.35M $10.64M $8.760M $7.950M $10.44M $12.66M $9.040M $6.240M $4.080M $2.220M $1.340M $10.00K $10.00K $0.00
YoY Change 15.02% 28.72% 63.58% 34.87% 21.46% 10.19% -23.85% -17.54% 40.04% 44.87% 52.94% 83.78% 65.67% 13300.0% 0.0%
% of Gross Profit 1148.07%
Research & Development $86.66M $81.88M $68.84M $36.16M $18.19M $17.56M $13.34M $28.53M $35.50M $18.62M $4.650M $2.584M $1.160M $580.0K $20.00K $10.00K $0.00
YoY Change 5.84% 18.94% 90.37% 98.79% 3.59% 31.63% -53.24% -19.64% 90.71% 300.37% 79.95% 122.76% 100.0% 2800.0% 100.0%
% of Gross Profit 2862.74%
Depreciation & Amortization $4.291M $1.253M $50.00K $30.00K $30.00K $50.00K $70.00K $210.0K $161.0K $36.00K $17.00K $14.00K $10.00K $0.00
YoY Change 242.46% 2406.0% 66.67% 0.0% -40.0% -28.57% -66.67% 30.43% 347.22% 111.76% 21.43% 40.0%
% of Gross Profit 141.76%
Operating Expenses $121.4M $81.88M $92.31M $50.51M $28.83M $26.32M $21.29M $38.97M $48.16M $27.66M $10.89M $6.662M $3.380M $1.930M $30.00K $20.00K $0.00
YoY Change 48.28% -11.31% 82.76% 75.2% 9.54% 23.63% -45.37% -19.09% 74.15% 154.0% 63.43% 97.1% 75.13% 6333.33% 50.0%
Operating Profit -$118.4M -$112.1M -$92.31M -$48.16M -$27.66M -$10.89M -$6.662M
YoY Change 5.61% 21.43% 74.15% 154.0% 63.43%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Interest Expense $1.873M $25.00K $50.00K $210.0K $230.0K $170.0K $130.0K $110.0K $40.00K $0.00 -$2.790M -$90.00K -$40.00K
YoY Change 7392.0% -50.0% -76.19% -8.7% 35.29% 30.77% 18.18% 175.0% -100.0% 3000.0% 125.0%
% of Operating Profit
Other Income/Expense, Net $1.722M $0.00 $0.00
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Pretax Income -$18.45M -$21.74M -$92.29M -$50.46M -$28.62M -$26.09M -$21.12M -$38.84M -$2.751M -$12.92M -$10.38M -$9.450M -$3.470M -$1.960M -$30.00K -$20.00K $0.00
YoY Change -15.11% -76.44% 82.89% 76.31% 9.7% 23.53% -45.62% 1311.85% -78.71% 24.48% 9.86% 172.33% 77.04% 6433.33% 50.0%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$116.7M -$110.2M -$92.29M -$50.46M -$28.62M -$26.09M -$21.12M -$38.84M -$48.05M -$27.62M -$10.88M -$9.450M -$3.470M -$1.964M -$221.0K -$202.0K $0.00
YoY Change 5.84% 19.43% 82.89% 76.31% 9.7% 23.53% -45.62% -19.17% 74.01% 153.73% 15.17% 172.33% 76.68% 788.69% 9.41%
Net Earnings / Revenue -1501.78% -90667.92%
Basic Earnings Per Share -$6.85 -$3.27 -$8.10
Diluted Earnings Per Share -$6.85 -$3.27 -$8.198M -$533.5K -$17.78M -$237.2M -$301.7M -$1.295B -$2.403B -$2.762B -$3.368B -$5.580B -$3.239B -$3.516B -$112.2M -$126.0M -$14.60M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Cash & Short-Term Investments $24.95M $120.2M $178.7M $77.07M $11.25M $25.03M $25.50M $26.12M $43.02M $38.18M $8.200M $1.790M $40.00K $70.00K $10.00K $40.00K $10.00K
YoY Change -79.25% -32.71% 131.82% 585.07% -55.05% -1.84% -2.37% -39.28% 12.68% 365.61% 358.1% 4375.0% -42.86% 600.0% -75.0% 300.0%
Cash & Equivalents $24.95M $120.2M $178.7M $77.07M $11.25M $25.03M $25.50M $18.94M $19.18M $38.18M $8.200M $1.790M $40.00K $70.00K $10.00K $40.00K $10.00K
Short-Term Investments $0.00 $7.180M $23.84M
Other Short-Term Assets $9.181M $10.55M $10.39M $10.92M $2.700M $1.020M $950.0K $1.020M $3.340M $850.0K $430.0K $220.0K $100.0K $20.00K $0.00 $10.00K $0.00
YoY Change -12.96% 1.53% -4.86% 304.44% 164.71% 7.37% -6.86% -69.46% 292.94% 97.67% 95.45% 120.0% 400.0% -100.0%
Inventory $13.64M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $47.77M $130.8M $189.0M $87.99M $13.95M $26.06M $26.44M $27.14M $46.36M $39.04M $8.630M $2.010M $140.0K $90.00K $10.00K $50.00K $10.00K
YoY Change -63.47% -30.82% 114.85% 530.75% -46.47% -1.44% -2.58% -41.46% 18.75% 352.38% 329.35% 1335.71% 55.56% 800.0% -80.0% 400.0%
Property, Plant & Equipment $94.85M $94.53M $51.47M $9.830M $390.0K $40.00K $90.00K $150.0K $350.0K $330.0K $50.00K $50.00K $30.00K $30.00K
YoY Change 0.34% 83.65% 423.62% 2420.51% 875.0% -55.56% -40.0% -57.14% 6.06% 560.0% 0.0% 66.67% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.129M $384.0K $259.0K $250.0K $100.0K $100.0K $100.0K $100.0K $190.0K $180.0K $60.00K $60.00K $260.0K $60.00K
YoY Change 194.01% 48.26% 3.6% 150.0% 0.0% 0.0% 0.0% -47.37% 5.56% 200.0% 0.0% -76.92% 333.33%
Total Long-Term Assets $106.7M $94.91M $51.85M $10.19M $610.0K $260.0K $310.0K $370.0K $660.0K $500.0K $110.0K $110.0K $290.0K $90.00K $0.00 $0.00 $0.00
YoY Change 12.41% 83.05% 408.84% 1570.49% 134.62% -16.13% -16.22% -43.94% 32.0% 354.55% 0.0% -62.07% 222.22%
Total Assets $154.5M $225.7M $240.9M $98.18M $14.56M $26.32M $26.75M $27.51M $47.02M $39.54M $8.740M $2.120M $430.0K $180.0K $10.00K $50.00K $10.00K
YoY Change
Accounts Payable $3.782M $8.068M $13.28M $4.600M $3.070M $1.400M $1.300M $870.0K $3.050M $1.490M $770.0K $830.0K $700.0K $320.0K $0.00 $0.00
YoY Change -53.12% -39.26% 188.74% 49.84% 119.29% 7.69% 49.43% -71.48% 104.7% 93.51% -7.23% 18.57% 118.75%
Accrued Expenses $5.374M $6.180M $4.929M $2.600M $1.040M $610.0K $70.00K $1.240M $3.600M $1.900M $1.170M $310.0K $50.00K $20.00K
YoY Change -13.04% 25.38% 89.58% 150.0% 70.49% 771.43% -94.35% -65.56% 89.47% 62.39% 277.42% 520.0% 150.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $280.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $2.350M $150.0K $0.00
YoY Change
Total Short-Term Liabilities $18.88M $18.18M $21.72M $9.820M $5.140M $2.660M $2.130M $2.120M $6.650M $3.380M $2.210M $1.140M $930.0K $340.0K $0.00 $0.00 $0.00
YoY Change 3.87% -16.28% 121.14% 91.05% 93.23% 24.88% 0.47% -68.12% 96.75% 52.94% 93.86% 22.58% 173.53%
Long-Term Debt $6.561M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.930M $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $23.49M $328.0K $467.0K $720.0K $10.00K $0.00 $10.00K $30.00K $110.0K $70.00K $10.00K $20.00K $30.00K $20.00K
YoY Change 7060.67% -29.76% -35.14% 7100.0% -100.0% -66.67% -72.73% 57.14% 600.0% -50.0% -33.33% 50.0%
Total Long-Term Liabilities $30.05M $328.0K $467.0K $720.0K $10.00K $0.00 $10.00K $30.00K $110.0K $70.00K $10.00K $20.00K $1.960M $20.00K $0.00 $0.00 $0.00
YoY Change 9060.98% -29.76% -35.14% 7100.0% -100.0% -66.67% -72.73% 57.14% 600.0% -50.0% -98.98% 9700.0%
Total Liabilities $48.93M $18.51M $22.18M $10.54M $5.140M $2.660M $2.140M $2.150M $6.760M $3.450M $2.220M $1.160M $2.880M $360.0K $0.00 $0.00 $0.00
YoY Change 164.38% -16.57% 110.46% 105.06% 93.23% 24.3% -0.47% -68.2% 95.94% 55.41% 91.38% -59.72% 700.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Basic Shares Outstanding 17.04M shares 35.74M shares 11.39M shares
Diluted Shares Outstanding 17.04M shares 35.74M shares 11.39M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $32.52 Million

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a US-based company operating in Biotechnology industry. The company is headquartered in Chatham, New Jersey and currently employs 103 full-time employees. The company went IPO on 2010-03-29. Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include Tonmya (TNX-102 SL), TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801 and TNX-1800. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. The company markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Industry: Pharmaceutical Preparations Peers: Elevation Oncology, Inc. 180 Life Sciences Corp. Serina Therapeutics, Inc. GeoVax Labs, Inc. eFFECTOR Therapeutics, Inc. Oncotelic Therapeutics, Inc. Oncorus, Inc. Regulus Therapeutics Inc.